Clinical Trial Update: Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects

View source ↗

Summary

This completed clinical trial evaluated the pharmacokinetics of ozanimod and its major metabolites in healthy subjects to characterize exposure and metabolic pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Ulcerative Colitis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Corium Innovations, Inc. | Conditions: Multiple Sclerosis, Ulcerative Colitis | Status: COMPLETED